Reduction of Parathyroid Hormone with Vitamin D Supplementation in Blacks: A Randomized Controlled Trial.

Published

Journal Article

Response of parathyroid hormone (PTH) to vitamin D supplementation is determined by the baseline PTH level and change in vitamin D status. Conflicting reports in Blacks exist on the PTH response to vitamin D to supplementation.During 3 winters from 2007-2010, 328 healthy Blacks (median age, 51 years) living in Boston, MA were randomized into a 4-arm, double-blind trial for 3 months of placebo, 1000, 2000, or 4000 IU of vitamin D3. PTH was measured in 254 participants at baseline and at the end of vitamin D supplementation period.The differences in PTH between baseline and 3 months were 3.93 pg/mL for those receiving placebo, -3.37 pg/mL for those receiving 1000 IU/d, -6.76 pg/mL for those receiving 2000 IU/d, and -8.99 pg/mL for those receiving 4000 IU/d ( -2.98 pg/mL for each additional 1000 IU/d of vitamin D3; p<0.001).We found a significant decrease in PTH with increasing doses of vitamin D supplementation up to intakes of 4000 IU/d in Blacks. Clinical Trials.gov: NCT00585637.

Full Text

Duke Authors

Cited Authors

  • Chandler, PD; Agboola, F; Ng, K; Scott, JB; Drake, BF; Bennett, GG; Chan, AT; Hollis, BW; Emmons, KM; Fuchs, CS; Giovannucci, EL

Published Date

  • January 2015

Published In

Volume / Issue

  • 1 /

PubMed ID

  • 26858840

Pubmed Central ID

  • 26858840

Electronic International Standard Serial Number (EISSN)

  • 2055-0928

International Standard Serial Number (ISSN)

  • 2055-0928

Digital Object Identifier (DOI)

  • 10.1186/s40795-015-0024-8

Language

  • eng